valsartan has been researched along with Retinopathy of Prematurity in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fletcher, EL; Hatzopoulos, KM; Vessey, KA; Wilkinson-Berka, JL | 1 |
| Downie, LE; Fletcher, EL; Hatzopoulos, KM; Kalloniatis, M; Pianta, MJ; Vingrys, AJ; Wilkinson-Berka, JL | 1 |
2 other study(ies) available for valsartan and Retinopathy of Prematurity
| Article | Year |
|---|---|
The vasoneuronal effects of AT1 receptor blockade in a rat model of retinopathy of prematurity.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Newborn; Disease Models, Animal; Electroretinography; Female; Fluorescent Antibody Technique, Indirect; Microglia; Microscopy, Confocal; Oxygen; Photic Stimulation; Photoreceptor Cells, Vertebrate; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Retinal Neovascularization; Retinal Vessels; Retinopathy of Prematurity; Tetrazoles; Valine; Valsartan | 2014 |
Angiotensin type-1 receptor inhibition is neuroprotective to amacrine cells in a rat model of retinopathy of prematurity.
Topics: Amacrine Cells; Amino Acids; Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Newborn; Color Vision; gamma-Aminobutyric Acid; Glycine; Humans; Infant, Newborn; Neuroprotective Agents; Random Allocation; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Retina; Retinopathy of Prematurity; Tetrazoles; Valine; Valsartan | 2010 |